Where have all the antibiotic patents gone?

Patent and regulatory hurdles combined with low returns on investment are stifling antibiotic R&D in the pharmaceutical industry.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature biotechnology 2006-12, Vol.24 (12), p.1529-1531
Hauptverfasser:	Katz, Martin L, Mueller, Lisa V, Polyakov, Mark, Weinstock, Steven F
Format:	Artikel
Sprache:	eng
Schlagworte:	Agriculture Anti-Bacterial Agents Antibiotics Bioinformatics Biological and medical sciences Biomedical Engineering/Biotechnology Biomedicine Biotechnology Drug Approval - economics Drug Approval - legislation & jurisprudence Drug Design Fundamental and applied biological sciences. Psychology Humans Legislation. General informations Life Sciences Patents as Topic - legislation & jurisprudence Pharmaceutical industry R&D Research & development Research - economics Research - trends
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Patent and regulatory hurdles combined with low returns on investment are stifling antibiotic R&D in the pharmaceutical industry.
ISSN:	1087-0156 1546-1696
DOI:	10.1038/nbt1206-1529